CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-08 | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +275,100 | 275,100 | ||
| 2025-03-08 | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2025-03-04 | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −4,109 | $1.71 | $7K | 112,720 |
| 2024-05-20 | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −22,337 | $5.61 | $125K | 116,829 |
| 2024-03-02 | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Grant or award | +35,300 | 113,200 | ||
| 2024-03-02 | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Grant or award | +25,966 | 139,166 | ||
| 2024-03-02 | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +106,000 | 106,000 | ||
| 2023-05-17 | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Grant or award | +77,900 | 77,900 | ||
| 2023-05-17 | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +155,800 | 155,800 |
Page 1 of 1 · 9 trades